section name header

Pronunciation

trye-floo-oh-PAIR-a-zeen

Classifications

Therapeutic Classification: antipsychotics (conventional)

Pharmacologic Classification: phenothiazines

Indications

REMS


Action

  • Alters the effects of dopamine in the CNS.
  • Possesses significant anticholinergic and alpha-adrenergic blocking activity.
Therapeutic effects:
  • Diminished signs and symptoms of psychoses.
  • Reduction in anxiety.

Pharmacokinetics

Absorption: Absorption from tablets is variable.

Distribution: Widely distributed, high concentrations in the CNS.

Protein Binding: 90%.

Metabolism/Excretion: Highly metabolized by the liver.

Half-Life: Unknown.

Time/Action Profile

(antipsychotic effects)

ROUTEONSETPEAKDURATION
POunknownunknown12–24 hr





Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: hypotension, tachycardia

Derm: photosensitivity, pigment changes, rash

EENT: blurred vision, dry eyes, lens opacities

Endo: amenorrhea, galactorrhea

GI: constipation, anorexia, dry mouth, hepatitis, ileus

GU: urinary retention, priapism

Hemat: AGRANULOCYTOSIS, leukopenia

Metab: hyperthermia

Neuro: extrapyramidal reactions, sedation, NEUROLEPTIC MALIGNANT SYNDROME, tardive dyskinesia

Misc: allergic reactions

Interactions

Drug-drug:

Route/Dosage

Availability

(Generic available)

Assessment

Lab Test Considerations:

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Stelazine